Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
IBI-3002 by Innovent Biologics for Asthma: Likelihood of Approval
IBI-3002 is under clinical development by Innovent Biologics and currently in Phase I for Asthma. According to GlobalData, Phase I...